Article
Estrogen receptor gene analysis in estrogen receptor-positive and receptor-negative primary breast cancer.
Journal of the National Cancer Institute - 15 Mar 1995
Roodi N, Bailey L R, Kao W Y, Verrier C S, Yee C J, Dupont W D, Parl F F
Abstract excerpt
BACKGROUND: In breast cancer patients, about two thirds of the tumors are estrogen receptor (ER)-positive and one third are ER-negative. The molecular mechanisms leading to the ER-negative phenotype are poorly understood. Nearly all ER-negative and about 40% of ER-positive cancers are resistant to endocrine therapy. PURPOSE: In this study, we examined the entire coding region of the ER gene in ER-positive and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
